logo-loader

Breakfast Alert - Audioboom, Hutchison China Medi, Ebiquity and more...

Published: 20:10 13 Feb 2018 AEDT

no_picture_pai

What’s cooking in the IPO kitchen?

AIM

TruFin—holding company of an operating group comprising three growth-focused FinTech and banking businesses operating in three niche lending markets: supply chain finance, invoice finance and dynamic discounting. Offer TBC, expected late Feb

Polarean  - The medical drug-device combination companies operating in the high resolution medical imaging market. Offer TBC. Due 22 Feb

Block Energy—a  NEX Listed UK based oil exploration and production company whose main country of operation is the Republic of Georgia, looks to join AIM end of February 2018. Offer TBC

 

Main Market Specialist Funds

Life Settlement—closed-ended investment company whose principal activities will be to support and manage portfolios of whole and partial interests in life settlement policies issued by life insurance companies operating predominantly in the US.  Due 6 Mar.

 

Main Market Premium Listing

IntegraFin provides platform services to UK clients and their financial advisers through its award-winning platform, Transact. Due Mar 18. FYSep2017 PBT up 44% to £29.9m.

GEMS Education—report by Reuters that the private schools group is seeking a $4.5bn to $5bn London float in 2018. FYAug17 rev $926.2m and adjusted EBITDA $261.6m.

CVC (Sky Bet) rumoured to be seeking £2.5bn plus float.

VC firm Augmentum rumoured to be seeking raise up to £125m.

                                                              

Breakfast buffet

Hutchison China Medi  (LON:HCM) 4,430p £2.9bn

“Hutchison China MediTech Limited has completed patient enrolment of FALUCA, its Phase III pivotal trial of fruquintinib in advanced, third-line, non-small cell lung cancer patients in China. Fruquintinib is a highly selective and potent oral inhibitor of vascular endothelial growth factor receptors 1, 2 and 3, that has met its primary endpoint in several Phase II and III clinical trials in China for the treatment of lung, colorectal and gastric cancers. Top-line FALUCA data is expected to be reported in late 2018 when the overall survival data is mature and, subject to a positive outcome, would be followed by a second New Drug Application ("NDA") submission thereafter. Fruquintinib's first NDA, for the treatment of colorectal cancer, was submitted to the China Food and Drug Administration in June 2017.”

Ebiquity (LON:EBQ) 100.5p £74.37m

“Ebiquity is pleased to announce it has entered into an agreement for the disposal of its AdIntel business to Nielsen Media Research Limited, a subsidiary of Nielsen Holdings plc, a global measurement and data analytics company. The consideration is £26m, payable in cash on completion, and subject to adjustments for working capital.”

“For the 12 months to 31 Dec Ebiquity continued to grow revenues by 4.9% to £87.6m, and 1.5% on a constant currency basis. Excluding the Market Intelligence segment, revenue grew by 7.0%, and by 3.3% on a constant currency basis. As anticipated revenue grew faster in H2 for the remaining Group, consisting of the Marketing Performance Optimization and Media Value Measurement practices, with constant currency revenue growth in the second half of the year of 7.3%.”

Craneware (LON:CRW) 1597p £420.8m

2 contract wins from The specialist “in Value Cycle solutions for the US healthcare market. Both hospital providers are new customers to Craneware. The first contract with a large blue chip healthcare provider, sees Craneware's Value Cycle products being deployed across this organisation's 20 hospitals. Craneware's solutions will be an integral part of this provider's major system change, helping to ensure revenue integrity during the initiative and beyond.  This contract is expected to deliver c$5m of revenue over its initial multi-year term. The second contract win with an innovative surgical hospital is for the provision of Craneware's suite of products as part of its strategic growth plans, deploying multiple Craneware solutions, including the Trisus Platform and Trisus Claims Informatics. This provider is focused on improving all aspects of its value cycle. This multi-year contract is expected to deliver c$3.5m of revenue over its initial term. FYJun18E rev $46.1m, PBT $13.7m yield c.1.4%.

Audioboom (LON:BOOM) 3.6p £33.5m

“The leading spoken word audio on-demand platform, announces the Company's intention to acquire the entire issued share capital of Triton Digital Canada Inc, the parent company of Triton Digital, Inc., for a cash consideration of $185m, (approximately £134m)”.

Proposing to raise approximately £155m, before expenses, through a proposed placing. The shares will be suspended under AIM rule 15.

For the year ended 31 Dec 2016, Triton recorded audited US GAAP turnover of approximately $40.9m and audited US GAAP EBITDA of approximately $9.0m (excluding non-recurring items).

During the first two months of the first quarter the Company's revenues and trading performance have been ahead of management's expectations. FYNov18E rev £15.01m, pre-tax loss £1m.

MC Mining (LON:MCM) 39.5p £55.65m

MC Mining Limited is pleased to announce that the South African Department of Water and Sanitation has granted an Integrated Water Use Licence in terms of the National Water Act (Act 36 of 1998) for the Vele Colliery's stream diversion and associated infrastructural activities.

This approval completes the full regulatory suite of all authorisations required for the Vele Colliery. As previously advised, the final decision on whether to proceed with the Plant Modification Project will be placed before the Company's Board, which will include an assessment of long term pricing as well as logistics considerations. The Board will evaluate all options available, which will be communicated at the appropriate time.

Venture Life Group (LON:VLG) 42.5p £15.66m

The international consumer healthcare group focused on developing, manufacturing and commercialising products for the self-care market, announces further distribution gains and launches for its leading oral care brand UltraDEX, together with other commercial progress.

Day Lewis Pharmacies (300 outlets), 460 Superdrug Stores, and all Roadchef outlets.

Q1 2018 will also see the launch of the Benecol liquid sachets in Jordan, their first market, following the successful registration with the Jordanian FDA. These sachets are a novel way of delivering the cholesterol reducing active, plant stanol esters.

2018 has started well for the whole Group, with the current order book ahead of the same point in 2017 and in line with management's expectations.  FYDec18E rev £18m and PBT £0.37m.

Oncimmune (LON:ONC) 145p £86.57m

HYNov17 results from the  early cancer detection Company. We have recently entered an exclusive distribution and product development agreement in China which includes a £10m equity investment and £15.7m in minimum royalties. We have now secured agreements for 12 countries with minimum sales commitments of £25.6m. We have also entered a preliminary distribution partnership with a major US pulmonology salesforce which is progressing well and, if successful, should lead to a significant distribution agreement focused on the risk detection of indeterminate pulmonary nodules - a large and growing market.

Revenues £0.1m generated from early sales of the EarlyCDT®-Lung test. Loss before one-off and non-cash items of £3.04m (2016: £2.3m) reflecting recruitment of staff, product development and commercialisation activities. Cash balance at the period end was £6.3m (H1 2016: £7.6m)  FYMay18E rev £1.15m and pre-tax loss £5.55m.

Smart Metering Systems (LON:SMS) 692p £778m

“The integrated metering services company that connects, owns, operates and maintains current generation and new advanced metering assets and databases, is pleased to announce that it has signed a new meter rental agreement with Utilita Energy to provide an opportunity for over 100,000 new meters during 2018, starting immediately.

Under the terms of the agreement, SMS will provide domestic smart meters as part of the UK Government programme, overseen by the Department of Business Energy and Industrial Strategy, requiring domestic energy supply companies to provide all of their customers with a smart meter in homes and small businesses across the UK by 2020.” FYDec18E rev £90.3m and PBT £27.23m.

Walls & Future REIT (AQSE:WAFR) 84.5p £2.8m

Walls & Futures REIT Plc is pleased to announce an Open Offer of new ordinary shares to raise up to £1.05m through the issue of up to 1,115,109 at a price of 94p per New Share to make further investments in the Supported Housing Sector.” The Issue Price represents a premium of 11.24% to the Company's mid-market price of 84.5p per share as at close of business on 9th February 2018.

National Milk Records (AQSE:NMR) 90.5p £19.2m

HYDec17 results from the UK supplier of dairy and livestock service.

* Turnover for continuing operations substantially increased to £10.5m  (2016: 39.4m) 

* Profit on ordinary activities, before taxation, of 3957,000 (2016: £442,000) 

* Cash generation from operations of £1.1m

* Net Debt decreased to £3.3m, or 1.4 times EBITDA

“Our focus in the second half of the year is to continue to provide exceptional service to our core milk recording customers whilst driving the market for improved testing for health and provenance and we expect continued growth in testing for Johne's disease and BVD.

 

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

5 hours, 43 minutes ago